(Q39434859)

English

Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 September 2017

Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trial (English)

1 reference

Europe PubMed Central

11 September 2017

0 references

author name string

Malmstrom K

1

1 reference

Europe PubMed Central

11 September 2017

Daniels S

2

1 reference

Europe PubMed Central

11 September 2017

Kotey P

3

1 reference

Europe PubMed Central

11 September 2017

Seidenberg BC

4

1 reference

Europe PubMed Central

11 September 2017

Desjardins PJ

5

1 reference

Europe PubMed Central

11 September 2017

publication date

1 October 1999

1 reference

Europe PubMed Central

11 September 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

11 September 2017

21

1 reference

Europe PubMed Central

11 September 2017

10

1 reference

Europe PubMed Central

11 September 2017

1653-1663

1 reference

Europe PubMed Central

11 September 2017

Cyclooxygenases as the principal targets for the actions of NSAIDs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980045-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of NSAID administration on tissue levels of immunoreactive prostaglandin E2, leukotriene B4, and (S)-flurbiprofen following extraction of impacted third molars.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980045-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostaglandin endoperoxide synthase: regulation of enzyme expression

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980045-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980045-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980045-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Five studies on ibuprofen for postsurgical dental pain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980045-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A crossover comparison of bromfenac sodium, naproxen sodium, and placebo for relief of pain from primary dysmenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980045-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The correlation between blood levels of ibuprofen and clinical analgesic response

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980045-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(99)80045-9

1 reference

Europe PubMed Central

11 September 2017

1 reference

Europe PubMed Central

11 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39434859&oldid=1827864223"